Chinese healthcare firms to raise $2 billion in HK IPOs
China NT Pharma and Shanghai Pharmaceuticals aim to raise as much as $2 billion in Hong Kong IPOs this month.
April 05, 2011
China NT Pharma Group raised HK$1.62 billion ($208 million) in a Hong Kong IPO last week, while Hilong Holdings pocketed HK$1.04 billion ($134 million) after a failed first attempt.
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].